The 340B program is vital for our partners and the patients they serve, so we work tirelessly to promote the importance of the program by educating the public at large and, when necessary, actively defend the 340B program from attacks by manufacturers who would otherwise pocket the proceeds for themselves.
In 2020, a handful of drug manufacturers either eliminated or significantly curtailed the 340B discounts that they are lawfully required to provide to 340B Covered Entities such as Ryan White Clinics and Federally Qualified Health Care Centers. These Entities care for some of the most vulnerable people in this country. So, we hit the ground running – engaging with HRSA and other key legislative officials, teaming with our covered entity partners to provide data which enables them to quantify the potential negative effect these decisions have on their patients, and actively engaging with national advocacy organizations to garner their support for the program. Avita deeply understands that our Covered Entity partners rely on 340B savings to achieve their mission of extending care to underserved people and communities, and we are passionate protecting patient access.
We also pride ourselves on being an integral part of the communities we serve by actively supporting them and giving back. We put a portion of our proceeds back into the community by sponsoring more than 150 partner and community events every year. Avita embraces cultural diversity, and we are committed to fostering an environment which inspires diversity of thought and perspective as we help our patients and partners unlock the full potential of health.